News Focus
News Focus
icon url

DewDiligence

05/22/17 7:56 PM

#211435 RE: DewDiligence #211386

RVNC—PropThink has a write-up on the CD data presented last week, but it’s behind a paywall, so I didn’t read it:

https://propthink.com/on-revances-latest-duration-of-benefit-data-with-rt002/
icon url

marthambles

05/25/17 10:21 AM

#211497 RE: DewDiligence #211386

Dew, are you aware of any stated bio-chemical reason explaining RT002's apparent duration superiority over Botox?

Thanks